Jennifer Thompson, Medtronic’s vice president of U.S. aortic sales, detailed how AI is transforming medical device commercialization during a fireside chat at Reuters’ MedTech conference. The technology is helping teams identify patients, optimize their sales deployment and discover care bottlenecks. The post Medtronic Exec: AI Is Improving Device Launches & Patient Outcomes appeared first on…
Employers are prioritizing mental wellbeing programs, but employees say they need financial wellbeing support, according to a survey from WTW. The post WTW: There’s A Disconnect Between Employers and Employees on Wellbeing Programs appeared first on MedCity News.
Hundreds of foreign doctors about to complete training in the U.S. will have to leave the country if the federal government doesn’t rapidly process their visa waiver applications, which have been languishing since the fall and winter, immigration attorneys say. The waiver program, run by the Department of Health and Human Services, allows physicians who…
This page tracks recent state actions to extend Medicaid postpartum coverage, including approved and pending 1115 waivers, legislation that will require the state to seek federal approval through a SPA or 1115 waiver, submitted and approved SPAs, and coverage financed solely with state funds.
Three-quarters of U.S. providers and payers say they have increased their IT spending over the past year, according to a new report from Bain & Company and KLAS Research. Both providers and payers are investing in cybersecurity technology, as well as AI tools. The post Providers and Payers Are Increasing Their Tech Spend — Where…
A judge temporarily blocked key parts of a Trump rule that would have restricted access to Marketplace coverage, marking a legal victory for Democrats and healthcare advocates who argued the rule would cause widespread coverage losses and violated federal law. The post Why a US Judge Paused Several Provisions of the Marketplace Rule appeared first…
Pfizer is in-licensing a bispecific antibody drug for cancer that China-based 3SBio designed to block the proteins PD-1 and VEGF. The deal puts the pharmaceutical giant in a growing group of companies developing bispecific antibodies for those targets, many of them with molecules originally developed in China. The post Pfizer Pledges $1.25B for Drug Candidate…
This analysis assesses the magnitude of combined U.S. and Global Fund funding cuts between 2026 and 2029, relative to prior funding levels, in 29 countries with signed MOUs and available data.
By MATTHEW HOLT (I copied this here from Linked in where it 65+ comments just so I can find it when the story continues) Too painful to write up fully but I am on my 4th transfer in one phone call to MarinHealth trying to get an echocardiogram (EDIT-not an EKG as I originally wrote)….
GenAI has real promise, but it’s also bringing real risks. It is not about whether we should use it but how we can use it responsibly and with positive outcomes. The post Shadow AI and the Governance Gap: Leading Healthcare Through the GenAI Revolution appeared first on MedCity News.